In the current study, we found that in women with PCOS, six months of GLP-1RA treatment resulted in a significant reduction in serum Fetuin-B levels, which was accompanied by ameliorated glucose metabolism and insulin sensitivity as indicated by elevated M values. The gene discussed is FETUB; the disease is polycystic ovary syndrome.